The global market for minimally invasive surgery (MIS) devices and instruments was worth an estimated $12 billion in 2005, and is expected to reach $12.9 billion in 2006 and $18.5 billion by 2011, an average annual growth rate (AAGR) of 7.5% between 2006 and 2011. (These figures include catheters, balloons, stents and other devices used in minimally invasive angioplasty.)
The U.S. accounted for about 60% of the world market, or $7.2 billion in 2005, and is growing at an AAGR of 7.2%. The U.S. market should reach $7.7 billion in 2006 and $11.0 billion by 2011.
Surgical devices (e.g, stents, catheters, guidewires) are the largest product segment of the U.S. minimally invasive surgery market, of which they accounted for about a 69% share in 2005. Monitoring and visualization systems were the second largest segment of the U.S. market in 2005, with an 11% market share, followed by endosurgical instruments (10%), electrosurgical equipment (8%), and robotics (2%). Surgical robots are the fastest-growing equipment /device segment, with an AAGR of 12% between 2006 and 2011, followed by surgical devices, with an AAGR of 8%.
Report Code: HLC051D, Published: June 2006, Analyst: Andrew McWilliams
INTRODUCTION
Minimally invasive surgery is performed without making a major incision or opening, resulting in less trauma for the patient and yielding significant cost savings. These result from shorter hospitalization times and reduced therapy requirements. Other benefits of minimally invasive surgery are less pain, less need for postsurgical pain medication, less scarring, and less likelihood of complications related to the incision.
Thus, minimally invasive surgery is defined either as based on the operative procedure (e.g., small incisions) or the outcome (reduced surgical complications or costs). However, minimally invasive is not the same as minor surgery. Some "minimally invasive" procedures, e.g., coronary artery bypass surgery, still are major operations requiring a hospital stay.
In minimally invasive surgery, a miniature camera is introduced into the body through a small incision. It transmits images to a video monitor, enabling the physician to diagnose and, if necessary, treat a variety of conditions. To do this, the physician inserts surgical instruments and auxiliary devices, such as irrigation and drainage devices, through one or more small incisions.
SCOPE OF STUDY
This report:
Identifies and segments the main types of minimally invasive devices and instruments that have been commercialized to date,
Analyzes the historical and current volume and value of shipments of each of these product segments in specified end-user and geographical markets,
Evaluates the impact of demographic, economic and other factors that will drive future demand for minimally invasive devices,
Forecasts the volume and value of shipments of the product segments,
Assesses promising surgical procedures and products in development, and forecasts their potential market,
Identifies leading manufacturers of the devices and analyzes the structure of the minimally invasive surgical devices industry,
Assesses the long-term outlook for the industry.
METHODOLOGY AND INFORMATION SOURCES
The findings and conclusions of this report are based on information gathered from manufacturers and users of minimally invasive surgical devices, as well as other informed sources. Interview data were combined with information gathered from an extensive review of secondary sources, such as trade publications, trade associations, company literature and online databases, to produce the market estimates contained in this report.
The base year for analysis and projection is 2005. At the time this report was prepared (early 2006), year-end data for 2005 were not yet universally available. Where necessary, market estimates for 2005 were developed using interim (partial) data for 2005, combined with historical data for the years 2002-2004.
With 2005 as a baseline, market projections were developed for 2006-2011. These projections are based on a consensus of primary contacts combined with BCC Research's understanding of the key market drivers and their impact from a historical and analytical perspective. The analytical methodologies used to generate the market estimates are described in detail in the section on Detailed Market Projections.
All dollar projections presented in this report are in 2005 constant dollars.
ANALYST CREDENTIALS
Andrew McWilliams is the author of this report. He is a partner in the Boston-based international technology and marketing consulting firm, 43rd Parallel LLC. Mr. McWilliams also is the author of several other BCC Research studies of the surgical and related health care markets. They include:
B-186R Patient Monitoring Devices
B-127R Microelectronic Medical Implants: Products, Technologies, and Opportunities
B-216 Prosthetics, Orthotics and Cosmetic Enhancement Products
B-207 Radiation-Based Therapy and Therapeutic Imaging
B-187 Drug Markets by Price Tier
B-182 Medical Robotics and Computer Assisted Surgery Market
